1
|
Sharma G, Sharma CS. Tetrahydropyridine appended 8-aminoquinoline derivatives: Design, synthesis, in silico, and in vitro antimalarial studies. Bioorg Chem 2024; 151:107674. [PMID: 39059071 DOI: 10.1016/j.bioorg.2024.107674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2024] [Revised: 07/22/2024] [Accepted: 07/23/2024] [Indexed: 07/28/2024]
Abstract
Antimalarial drug resistance is a major obstacle in the ongoing quest against malaria. The disease affects half of the world's population. The majority of them are toddlers and pregnant women. Needed a potent compound to act on drug-resistant Pf at appropriate concentrations without endangering the host. Envisaged solving this issue through rational drug design by creating a novel hybrid drug possessing two pharmacophores that can act on two marvellous and independent aims within the cell. Synthesized a new series of substituted 4-phenyl-1,2,3,6-tetrahydropyridine (THP) 8-Aminoquinoline-based hybrid analogs which have been integrated with quinoline, chloroquine, pamaquine, and primaquine, which exhibited antimalarial activity against Pf. Out of thirteen 4-phenyl-1,2,3,6-THP appended 8-Aminoquinoline derivatives, the compounds 1j, 1e, 1b, and 1l have exhibited good antimalarial activity against chloroquine-sensitive (3D7) and chloroquine-resistant (RKL-9) strain with the minimum inhibitory concentration. Compound 1b was the most effective and showed consistently good potency against the drug-resistant (RKL-9) strain, although all other arrays showed good antimalarial efficacy. Additional docking and molecular dynamics studies were carried out at several targeting sites to quantify the structural parameters necessary for the activity.
Collapse
Affiliation(s)
- Ganesh Sharma
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, Rajasthan 313001, India.
| | - C S Sharma
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, Rajasthan 313001, India
| |
Collapse
|
2
|
Xiang Y, Xu Y, Li J, Jiang J, Wang Y, Li X, Ai W, Mi P, Yang Z, Zheng Z. A Review on the Mechanism and Structure-activity Relationship of Resveratrol Heteroaryl Analogues. Comb Chem High Throughput Screen 2024; 27:947-958. [PMID: 37448369 DOI: 10.2174/1386207326666230713125512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 02/19/2023] [Accepted: 03/15/2023] [Indexed: 07/15/2023]
Abstract
Resveratrol is one of the most interesting naturally-occurring nonflavonoid phenolic compounds with various biological activities, such as anticancer, neuroprotection, antibacterial, and anti-inflammatory. However, there is no clinical usage of resveratrol due to either its poor activity or poor pharmacokinetic properties. Heteroarenes-modified resveratrol is one pathway to improve its biological activities and bioavailability, and form more modification sites. In this review, we present the progress of heteroaryl analogues of resveratrol with promising biological activities in the latest five years, ranging from the synthesis to the structure-activity relationship and mechanism of actions. Finally, introducing heteroarenes into resveratrol is an effective strategy, which focuses on the selectivity of structure-activity relationship in vivo.
Collapse
Affiliation(s)
- Yijun Xiang
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Yao Xu
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Jiaxin Li
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Jingyi Jiang
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Yanjie Wang
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Xiaoshun Li
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Wenbin Ai
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Pengbing Mi
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Zehua Yang
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| | - Zitong Zheng
- Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China
| |
Collapse
|
3
|
Synthesis, Molecular Docking, and Antimalarial Activity of Hybrid 4-Aminoquinoline-pyrano[2,3-c]pyrazole Derivatives. Pharmaceuticals (Basel) 2021; 14:ph14111174. [PMID: 34832956 PMCID: PMC8622706 DOI: 10.3390/ph14111174] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 11/09/2021] [Accepted: 11/09/2021] [Indexed: 11/24/2022] Open
Abstract
Widespread resistance of Plasmodium falciparum to current artemisinin-based combination therapies necessitate the discovery of new medicines. Pharmacophoric hybridization has become an alternative for drug resistance that lowers the risk of drug–drug adverse interactions. In this study, we synthesized a new series of hybrids by covalently linking the scaffolds of pyrano[2,3-c]pyrazole with 4-aminoquinoline via an ethyl linker. All synthesized hybrid molecules were evaluated through in vitro screenings against chloroquine-resistant (K1) and -sensitive (3D7) P. falciparum strains, respectively. Data from in vitro assessments showed that hybrid 4b displayed significant antiplasmodial activities against the 3D7 strain (EC50 = 0.0130 ± 0.0002 μM) and the K1 strain (EC50 = 0.02 ± 0.01 μM), with low cytotoxic effect against Vero mammalian cells. The high selectivity index value on the 3D7 strain (SI > 1000) and the K1 strain (SI > 800) and the low resistance index value from compound 4b suggested that the pharmacological effects of this compound were due to selective inhibition on the 3D7 and K1 strains. Molecular docking analysis also showed that 4b recorded the highest binding energy on P. falciparum lactate dehydrogenase. Thus, P. falciparum lactate dehydrogenase is considered a potential molecular target for the synthesized compound.
Collapse
|
4
|
Nqoro X, Jama S, Morifi E, Aderibigbe BA. 4-Aminosalicylic Acid-based Hybrid Compounds: Synthesis and In vitro Antiplasmodial Evaluation. LETT DRUG DES DISCOV 2021. [DOI: 10.2174/1570180817999200802031547] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Background:
Malaria is a deadly and infectious disease responsible for millions of death
worldwide, mostly in the African region. The malaria parasite has developed resistance to the currently
used antimalarial drugs, and it has urged researchers to develop new strategies to overcome
this challenge by designing different classes of antimalarials.
Objectives:
A class of hybrid compounds containing 4-aminosalicylic acid moiety was prepared via
esterification and amidation reactions and characterized using FTIR, NMR and LC-MS. In vitro antiplasmodial
evaluation was performed against the asexual NF54 strain of P. falciparum parasites.
Methods:
In this research, known 4-aminoquinoline derivatives were hybridized with 4-
aminosalicylic acid to afford hybrid compounds via esterification and amidation reactions. 4-
aminosalicylic acid, a dihydrofolate compound inhibits DNA synthesis in the folate pathway and is
a potential pharmacophore for the development of antimalarials.
Results:
The LC-MS, FTIR, and NMR analysis confirmed the successful synthesis of the compounds.
The compounds were obtained in yields in the range of 63-80%. The hybrid compounds
displayed significant antimalarial activity when compared to 4-aminosalicylic acid, which exhibited
poor antimalarial activity. The IC50 value of the most potent hybrid compound, 9 was 9.54±0.57 nm.
Conclusion:
4-aminosalicylic has different functionalities, which can be used for hybridization with
a wide range of compounds. It is a potential pharmacophore that can be utilized for the design of
potent antimalarial drugs. It was found to be a good potentiating agent when hybridized with 4-
aminoquinoline derivatives suggesting that they can be utilized for the synthesis of a new class of
antimalarials.
Collapse
Affiliation(s)
- Xhamla Nqoro
- Department of Chemistry, University of Fort Hare, Alice Campus,South Africa
| | - Siphesihle Jama
- Department of Chemistry, University of Fort Hare, Alice Campus,South Africa
| | - Eric Morifi
- School of Chemistry, Mass Spectrometry Division, University of the Witwatersrand, Johannesburg Private Bag X3, WITS, 2050,South Africa
| | | |
Collapse
|
5
|
Peter S, Morifi E, Aderibigbe BA. Hybrid Compounds Containing a Ferrocene Scaffold as Potential Antimalarials. ChemistrySelect 2021. [DOI: 10.1002/slct.202004710] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Sijongesonke Peter
- Department of Chemistry University of Fort Hare, Alice Campus Alice 5700, Eastern Cape South Africa
| | - Eric Morifi
- School of Chemistry, Mass Spectrometry Division University of Witwatersrand, Johannesburg Private Bag X3 WITS 2050 South Africa
| | - Blessing A. Aderibigbe
- Department of Chemistry University of Fort Hare, Alice Campus Alice 5700, Eastern Cape South Africa
| |
Collapse
|
6
|
Wang C, Zhang X, Ma X, Ai Y, Ren Y, Bai X, Chen H, Zhou Y, Li W, Liu Y. Microwave-Assisted and Solvent-Free Synthesis of Quinoline Derivatives and Their Fluorescence Properties. HETEROCYCLES 2021. [DOI: 10.3987/com-20-14384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
7
|
Huang G, Murillo Solano C, Melendez J, Shaw J, Collins J, Banks R, Arshadi AK, Boonhok R, Min H, Miao J, Chakrabarti D, Yuan Y. Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines. J Med Chem 2020; 63:11756-11785. [PMID: 32959656 DOI: 10.1021/acs.jmedchem.0c00858] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
There is an urgent need to develop new efficacious antimalarials to address the emerging drug-resistant clinical cases. Our previous phenotypic screening identified styrylquinoline UCF501 as a promising antimalarial compound. To optimize UCF501, we herein report a detailed structure-activity relationship study of 2-arylvinylquinolines, leading to the discovery of potent, low nanomolar antiplasmodial compounds against a Plasmodium falciparum CQ-resistant Dd2 strain, with excellent selectivity profiles (resistance index < 1 and selectivity index > 200). Several metabolically stable 2-arylvinylquinolines are identified as fast-acting agents that kill asexual blood-stage parasites at the trophozoite phase, and the most promising compound 24 also demonstrates transmission blocking potential. Additionally, the monophosphate salt of 24 exhibits excellent in vivo antimalarial efficacy in the murine model without noticeable toxicity. Thus, the 2-arylvinylquinolines represent a promising class of antimalarial drug leads.
Collapse
Affiliation(s)
- Guang Huang
- Department of Chemistry, University of Central Florida, Orlando, Florida 32816, United States
| | - Claribel Murillo Solano
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Joel Melendez
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Justin Shaw
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Jennifer Collins
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Robert Banks
- Research Program Services, University of Central Florida, Orlando, Florida 32816, United States
| | - Arash Keshavarzi Arshadi
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Rachasak Boonhok
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States.,Department of Medical Technology, School of Allied Health Science, Walailak University, Nakhon Si Thammarat 80160, Thailand
| | - Hui Min
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States
| | - Jun Miao
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States
| | - Debopam Chakrabarti
- Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States
| | - Yu Yuan
- Department of Chemistry, University of Central Florida, Orlando, Florida 32816, United States
| |
Collapse
|
8
|
Srbljanović J, Bobić B, Štajner T, Uzelac A, Opsenica I, Terzić-Jovanović N, Bauman N, Šolaja BA, Djurković-Djaković O. Aminoquinolines afford resistance to cerebral malaria in susceptible mice. J Glob Antimicrob Resist 2020; 23:20-25. [PMID: 32810640 DOI: 10.1016/j.jgar.2020.07.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 07/07/2020] [Accepted: 07/31/2020] [Indexed: 10/23/2022] Open
Abstract
OBJECTIVES Malaria treatment is impeded by increasing resistance to conventional antimalarial drugs. Here we explored the activity of ten novel benzothiophene, thiophene and benzene aminoquinolines. METHODS In vitro testing was performed by the lactate dehydrogenase assay in chloroquine (CQ)-sensitive Plasmodium falciparum strain 3D7 and CQ-resistant (CQR) P. falciparum strain Dd2. In vivo activity was evaluated by a modified Thompson test using C57BL/6 mice infected with Plasmodium berghei ANKA strain. RESULTS Nine of the ten compounds had a lower 50% inhibitory concentration (IC50) than CQ against the CQR strain Dd2. Five of these compounds that were available for in vivo evaluation were shown to be non-toxic. All five compounds administered at a dose of 160mg/kg/day for 3 days prolonged the survival of treated compared with untreated mice. Untreated control mice died by Day 7 with a mean parasitaemia of 15%. Among treated mice, a dichotomous outcome was observed, with a two-third majority of treated mice dying by Day 17 with a low mean parasitaemia of 5%, whilst one-third survived longer with a mean hyperparasitaemia of 70%; specifically, five of these mice survived a mean of 25 days, whilst two even survived past Day 31. CONCLUSIONS The significant antimalarial potential of this aminoquinoline series is illustrated by its excellent in vitro activity against the CQRP. falciparum strain and significant in vivo activity. Interestingly, compounds ClAQ7, ClAQ9 and ClAQ11 were able to confer resistance to cerebral malaria and afford a switch to hyperparasitaemia to mice prone to the neurological syndrome.
Collapse
Affiliation(s)
- Jelena Srbljanović
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia
| | - Branko Bobić
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia
| | - Tijana Štajner
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia
| | - Aleksandra Uzelac
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia
| | - Igor Opsenica
- Faculty of Chemistry, University of Belgrade, Studentski trg 16, P.O. Box 51, 11158 Belgrade, Serbia
| | | | - Neda Bauman
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia
| | - Bogdan A Šolaja
- Faculty of Chemistry, University of Belgrade, Studentski trg 16, P.O. Box 51, 11158 Belgrade, Serbia; Serbian Academy of Sciences and Arts, Knez Mihailova 35, 11000 Belgrade, Serbia
| | - Olgica Djurković-Djaković
- Institute for Medical Research, University of Belgrade, Dr. Subotića 4, P.O. Box 39, 11129 Belgrade, Serbia.
| |
Collapse
|
9
|
Joshi MC, Egan TJ. Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application. Curr Top Med Chem 2020; 20:617-697. [DOI: 10.2174/1568026620666200127141550] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 10/25/2019] [Accepted: 10/30/2019] [Indexed: 01/16/2023]
Abstract
The side-chains of quinoline antimalarial agents are the major concern of focus to build
novel and efficaciaous bioactive and clinical antimalarials. Bioative antimalarial analogs may play a
critical role in pH trapping in the food vacuole of RBC’s with the help of fragmented amino acid, thus
lead to β-hematin inhibition. Here, the authors tried to summarize a useful, comprehensive compilation
of side-chain modified ACQs along with their synthesis, biophysical and therapeutic applications etc.
of potent antiplasmodial agents and therefore, opening the door towards the potential clinical status.
Collapse
Affiliation(s)
- Mukesh C. Joshi
- Department of Chemistry, Motilal Nehru College, Benito Juarez Marg, South Campus, University of Delhi, New Delhi- 110021, India
| | - Timothy J. Egan
- Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa
| |
Collapse
|
10
|
Du Z, Yang H, Lv WJ, Zhang XY, Zhai HL. Prediction of the inhibitory concentrations of chloroquine derivatives using deep neural networks models. J Biomol Struct Dyn 2020; 39:672-680. [PMID: 31918625 DOI: 10.1080/07391102.2020.1714486] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
In recent years, deep neural networks have begun to receive much attention, which has obvious advantages in feature extraction and modeling. However, in the using of deep neural networks for the QSAR modeling process, the selection of various parameters (number of neurons, hidden layers, transfer functions, data set partitioning, number of iterations, etc.) becomes difficult. Thus, we proposed a new and easy method for optimizing the model and selecting Deep Neural Networks (DNN) parameters through uniform design ideas and orthogonal design methods. By using this approach, 222 chloroquine (CQ) derivatives with half maximal inhibitory concentration values reported in different kinds of literature were selected to establish DNN models and a total number of 128,000 DNN models were built to determine the optimized parameters for selecting the better models. Comparing with linear and Artificial Neural Network (ANN) models, we found that DNN models showed better performance.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Zhe Du
- Department of Chemistry, Lanzhou University, Lanzhou, PR China
| | - Hong Yang
- Department of Chemistry, Lanzhou University, Lanzhou, PR China
| | - Wen-Juan Lv
- Department of Chemistry, Lanzhou University, Lanzhou, PR China
| | - Xiao-Yun Zhang
- Department of Chemistry, Lanzhou University, Lanzhou, PR China
| | - Hong-Lin Zhai
- Department of Chemistry, Lanzhou University, Lanzhou, PR China
| |
Collapse
|
11
|
Sharma B, Kaur S, Legac J, Rosenthal PJ, Kumar V. Synthesis, anti-plasmodial and cytotoxic evaluation of 1H-1,2,3-triazole/acyl hydrazide integrated tetrahydro-β-carboline-4-aminoquinoline conjugates. Bioorg Med Chem Lett 2020; 30:126810. [DOI: 10.1016/j.bmcl.2019.126810] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 11/01/2019] [Accepted: 11/04/2019] [Indexed: 12/20/2022]
|
12
|
Aguiar ACC, Murce E, Cortopassi WA, Pimentel AS, Almeida MMFS, Barros DCS, Guedes JS, Meneghetti MR, Krettli AU. Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity. Int J Parasitol Drugs Drug Resist 2018; 8:459-464. [PMID: 30396013 PMCID: PMC6215995 DOI: 10.1016/j.ijpddr.2018.10.002] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Revised: 10/11/2018] [Accepted: 10/13/2018] [Indexed: 11/18/2022]
Abstract
In spite of recent efforts to eradicate malaria in the world, this parasitic disease is still considered a major public health problem, with a total of 216 million cases of malaria and 445,000 deaths in 2016. Artemisinin-based combination therapies remain effective in most parts of the world, but recent cases of resistance in Southeast Asia have urged for novel approaches to treat malaria caused by Plasmodium falciparum. In this work, we present chloroquine analogs that exhibited high activity against sensitive and chloroquine-resistant P. falciparum blood parasites and were also active against P. berghei infected mice. Among the compounds tested, DAQ, a chloroquine analog with a more linear side chain, was shown to be the most active in vitro and in vivo, with low cytotoxicity, and therefore may serve as the basis for the development of more effective chloroquine analogs to aid malaria eradication.
Collapse
Affiliation(s)
- Anna C C Aguiar
- Centro de Pesquisas Rene Rachou, Laboratório de Malária, Belo Horizonte, Brazil
| | - Erika Murce
- Pontifical Catholic University of Rio de Janeiro, Department of Chemistry, Rio de Janeiro, Brazil
| | - Wilian A Cortopassi
- University of California, San Francisco, Department of Pharmaceutical Chemistry, USA.
| | - Andre S Pimentel
- Pontifical Catholic University of Rio de Janeiro, Department of Chemistry, Rio de Janeiro, Brazil
| | - Maria M F S Almeida
- Universidade Federal de Alagoas, Instituto de Química e Biotecnologia, Maceió, Brazil
| | - Daniele C S Barros
- Universidade Federal de Alagoas, Instituto de Química e Biotecnologia, Maceió, Brazil
| | - Jéssica S Guedes
- Universidade Federal de Alagoas, Instituto de Química e Biotecnologia, Maceió, Brazil
| | - Mario R Meneghetti
- Universidade Federal de Alagoas, Instituto de Química e Biotecnologia, Maceió, Brazil
| | - Antoniana U Krettli
- Centro de Pesquisas Rene Rachou, Laboratório de Malária, Belo Horizonte, Brazil
| |
Collapse
|
13
|
Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chiral Chloroquine Analogues as Antimalarial Agents. Antimicrob Agents Chemother 2018; 62:AAC.02347-17. [PMID: 30224532 DOI: 10.1128/aac.02347-17] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Accepted: 08/16/2018] [Indexed: 11/20/2022] Open
Abstract
In a focused exploration, we designed, synthesized, and biologically evaluated chiral conjugated new chloroquine (CQ) analogues with substituted piperazines as antimalarial agents. In vitro as well as in vivo studies revealed that compound 7c showed potent activity (in vitro 50% inhibitory concentration, 56.98 nM for strain 3D7 and 97.76 nM for strain K1; selectivity index in vivo [up to at a dose of 12.5 mg/kg of body weight], 3,510) as a new lead antimalarial agent. Other compounds (compounds 6b, 6d, 7d, 7h, 8c, 8d, 9a, and 9c) also showed moderate activity against a CQ-sensitive strain (3D7) and superior activity against a CQ-resistant strain (K1) of Plasmodium falciparum Furthermore, we carried out docking and three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of all in-house data sets (168 molecules) of chiral CQ analogues to explain the structure-activity relationships (SAR). Our new findings specify the significance of the H-bond interaction with the side chain of heme for biological activity. In addition, the 3D-QSAR study against the 3D7 strain indicated the favorable and unfavorable sites of CQ analogues for incorporating steric, hydrophobic, and electropositive groups to improve the antimalarial activity.
Collapse
|
14
|
Kondaparla S, Manhas A, Dola VR, Srivastava K, Puri SK, Katti SB. Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline. Bioorg Chem 2018; 80:204-211. [PMID: 29940342 DOI: 10.1016/j.bioorg.2018.06.012] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Revised: 06/03/2018] [Accepted: 06/04/2018] [Indexed: 10/14/2022]
Abstract
A series of short chain 4-aminoquinoline-imidazole derivatives have been synthesized in one pot two step multicomponent reaction using van leusen standard protocol. The diethylamine function of chloroquine is replaced by substituted imidazole derivatives containing tertiary terminal nitrogen. All the synthesized compounds were screened against the chloroquine sensitive (3D7) and chloroquine resistant (K1) strains of Plasmodium falciparum. Some of the compounds (6, 8, 9 and 17) in the series exhibited comparable activity to CQ against K1 strain of P. falciparum. All the compounds displayed resistance factor between 0.09 and 4.57 as against 51 for CQ. Further, these analogues were found to form a strong complex with hematin and inhibit the β-hematin formation, therefore these compounds act via heme polymerization target.
Collapse
Affiliation(s)
- Srinivasarao Kondaparla
- Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India.
| | - Ashan Manhas
- Parasitology Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Vasantha Rao Dola
- Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Kumkum Srivastava
- Parasitology Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Sunil K Puri
- Parasitology Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - S B Katti
- Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| |
Collapse
|
15
|
Kumar S, Bhardwaj TR, Prasad DN, Singh RK. Drug targets for resistant malaria: Historic to future perspectives. Biomed Pharmacother 2018; 104:8-27. [PMID: 29758416 DOI: 10.1016/j.biopha.2018.05.009] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Revised: 04/22/2018] [Accepted: 05/07/2018] [Indexed: 01/05/2023] Open
Abstract
New antimalarial targets are the prime need for the discovery of potent drug candidates. In order to fulfill this objective, antimalarial drug researches are focusing on promising targets in order to develop new drug candidates. Basic metabolism and biochemical process in the malaria parasite, i.e. Plasmodium falciparum can play an indispensable role in the identification of these targets. But, the emergence of resistance to antimalarial drugs is an escalating comprehensive problem with the progress of antimalarial drug development. The development of resistance has highlighted the need for the search of novel antimalarial molecules. The pharmaceutical industries are committed to new drug development due to the global recognition of this life threatening resistance to the currently available antimalarial therapy. The recent developments in the understanding of parasite biology are exhilarating this resistance issue which is further being ignited by malaria genome project. With this background of information, this review was aimed to highlights and provides useful information on various present and promising treatment approaches for resistant malaria, new progresses, pursued by some innovative targets that have been explored till date. This review also discusses modern and futuristic multiple approaches to antimalarial drug discovery and development with pictorial presentations highlighting the various targets, that could be exploited for generating promising new drugs in the future for drug resistant malaria.
Collapse
Affiliation(s)
- Sahil Kumar
- School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Dist. Solan, 173205, Himachal Pradesh, India
| | - T R Bhardwaj
- School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Dist. Solan, 173205, Himachal Pradesh, India
| | - D N Prasad
- Department of Pharmaceutical Chemistry, Shivalik College of Pharmacy, Nangal, Dist. Rupnagar, 140126, Punjab, India
| | - Rajesh K Singh
- Department of Pharmaceutical Chemistry, Shivalik College of Pharmacy, Nangal, Dist. Rupnagar, 140126, Punjab, India.
| |
Collapse
|